top of page

Supporting Families While Advancing Research to Find Treatment for DLG4 SHINE

Cedric-Family.jpg
IMG_1436.heic
IMG_1436.heic

DLG4 Synaptopathy, or DLG4 SHINE is an ultra-rare disease caused by a genetic mutation on the 17th Chromosome. Patients living with DLG4 SHINE typically endure trouble with Sleep Disturbances, Hypotonia, Intellectual Disabilities, Neurological Disorders, and Epilepsy, thus the name “SHINE”.

Cedric-Family.jpg
Creek 2023 142 of 176.jpg
IMG_5038 2 - Courtney Roche.HEIC

3

Research Studies

$675,000

Fundraised In Three Years

190

Known Individuals Diagnosed

Our SHINEing Stars

Although they navigate numerous struggles in their daily lives, our SHINEing stars are generally all smiles, love to celebrate even the smallest victories, and spread joy wherever they go.

Announcements

Our Partners

From Our Families

SHINE A Light On DLG4 - A Family Documentary

DLG4 SHINE secured a grant in 2022 to develop a documentary film about this rare disease. This video offers a glimpse into the lives of families by families affected by DLG4 SHINE. Learn characteristics of the disease and how fundraising and current research initiatives can help those affected.

Website news.jpg

Citizen Health "Share for Rare"

We're reaching out to our U.S.-based families and asking them to sign up for Citizen Health to help power digital natural history studies for our community!

By participating, you will be part of something truly meaningful: a chance to contribute to vital research that could change the future of care for so many families like ours.

Our goal is to have at least 25 new patient families join by November 30 so that we can generate our first core natural history dataset with Citizen!

Sign up here: www.citizen.health/partners/shine-syndrome

Website news.jpg

The Science of DLG4 webinar series

We've recently started hosting a series of live webinars on various scientifc topics for the DLG4 SHINE patient community.

Keep an eye on our Facebook page for the details of the next live webinar and check out our YouTube channel to see the recording of past webinars.

Website news.jpg

FDA Patient Listening Session

On July 17th, 2024, the Foundation held a Patient-led Listening Session with the Food and Drug Administration.

The objective of the session was to provide FDA staff with an opportunity to hear about the wide spectrum of experiences and perspectives of various patients and families living with DLG4 SHINE in order to understand the complexity of the disease and its impact on their daily lives, what they would consider meaningful treatment outcomes, and their risk tolerances to achieve said outcomes.

Website news.jpg

A Rebrand is happening

With a few successful years of advocacy and research efforts, the fast increasing number of diagnosed patients, and the lucky addition to the board of a Mom with marketing expertise we have decided to rebrand in order to professionalize and grow the foundation further.

Click on About to read more about the history of the Foundation and the reasoning behind our meaningful choices.

bottom of page